Download this measure in English. BACK PROMIS SF v1.0-Dyspnea-Functional Limitations 5b English Downloads Download PDF Download DOC

Download scoring documents for this measure. BACK PROMIS SF v1.0-Dyspnea-Severity 5b Scoring Downloads http://www.healthmeasures.net/score-and-interpret/ calculate-scores/scoring-instructions

View all available languages for this measure. BACK FAMS Languages Arabic Bulgarian Chinese - Traditional Croatian Czech Danish Dutch English Farsi Finnish French German Greek Hebrew Hungarian Italian Japanese Korean Norwegian Polish Portuguese Romanian Russian Serbian Slovak Spanish Swedish Turkish Ukrainian

See the most current list of measures available to license from FACIT.org. Permission for use can be obtained by selecting 'license this measure' on any measure's page. FACIT Measures & Languages OVER 100 MEASURES IN AS MANY AS 80 LANGUAGES Below is a current list of measures available to license from FACIT.org. Permission for use must be obtained by selecting 'license this measure' on any measure's page. Generally, licensing fees are waived for non-profit organizations and clinical settings. A licensing fee will be assessed if the user or any associate of the user intends to use the FACIT system for any commercial or other financially profitable purpose in the context of the relevant study or data. Measures General Measures Cancer-Specific Measures Cancer-Specific Symptom Indexes Treatment-Specific Measures Symptom-Specific Measures Financial Toxicity Disease-Specific Measures Pallative Care and Spiritual Well-Being Treatment Satisfaction Utility Indexes Pediatric Measures PROMIS Measures Additional Measures

FACT-Br-CI Functional Assessment of Cancer Therapy – Brain Cognitive Index For patients with Brain cancer LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The FACT-Br-CI measures self-reported cognition in patients with brain cancer. Studies that included the FACT-Br could be retrospectively analyzed to assess subjective cognitive outcomes, enriching the information from prior research. Integration of the FACT-Br-CI in routine clinical care may be an efficient method of monitoring cognition. MEASURE NAME: Functional Assessment of Cancer Therapy – Brain Cognitive Index (FACT-Br-CI) VERSION: 4 NUMBER OF ITEMS: 9 PATIENT POPULATION: Brain cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Cognitive Index TIME FOR COMPLETION: 5 minutes SCORING: Manual scoring template, some items are reverse scored. RELATED MEASURES: FBrSI , NFBrSI-24 , FACT-Br DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-Br-CI can be obtained by registering for permission. Users are not permitted to translate the FACT-Br-CI without permission from FACIT.org. Permission from FACIT.org to translate the FACT-Br-CI may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Zarrella GV, Perez A, Dietrich J, Parsons MW. Reliability and validity of a novel cognitive self-assessment tool for patients with cancer. Neurooncol Pract . 2021 Jul 21;8(6):691-698. doi: 10.1093/nop/npab045. PMID: 34777838; PMCID: PMC8579089. Weitzner, M.A., Meyers, C.A., Gelke, C., Byrne, K., Cella, D.F., & Levin, V.A. The Functional Assessment of Cancer Therapy (FACT) Scale: Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995; 75(5): 1151-1161. Thavarajah, N., Bedard, G., Zhang, L., Cella, D., Beaumont, J., Tsao, M., Barnes, E., Danjoux, C., Sahgal, A., Soliman, H., & Chow, E. The Functional Assessment of Cancer Therapy – Brain (FACT-Br) for assessing quality of life in patients with brain metastases: A comparison of recall periods. Journal of Pain Management 2013; 6(3): 223-234. Thavarajah, N., G., Zhang, L., Cella, D., Beaumont, J. Tsao, M., Barnes, E., Danjoux, C., Sahgal, A., Soliman, H., & Chow, E. Psychometric validation of the functional assessment of cancer therapy—brain (FACT-Br) for assessing quality of life in patients with brain metastases Supportive Care in Cancer 2014; 22 (4): 1017-1028. doi: 10.1007/s00520-013-2060-8. Verhaak, E., Schimmel, W. C., Sitskoorn, M. M., Bakker, M., Hanssens, P. E., & Gehring, K. (2019). Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery. Journal of neuro-oncology , 144 (2), 377-384. Verhaak, E., Gehring, K., Hanssens, P. E., & Sitskoorn, M. M. (2019). Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery. Journal of neuro-oncology , 143 (3), 537-546. Verhaak, E., Schimmel, W. C., Gehring, K., Emons, W. H., Hanssens, P. E., & Sitskoorn, M. M. (2020). Health-related quality of life after Gamma Knife radiosurgery in patients with 1–10 brain metastases. Journal of Cancer Research and Clinical Oncology , 1-11. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FBrSI Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 15 Item Version LEARN MORE NRBrSI-24 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 24 Item Version LEARN MORE FACT-Br Functional Assessment of Cancer Therapy – Brain LEARN MORE

FACT-Bl-Cys Functional Assessment of Cancer Therapy – Bladder – Cystectomy For patients undergoing cystectomy (formerly FACT-VCI) LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys), originally developed as the FACT – Vanderbilt Cystectomy Index (FACT-VCI), is a condition-specific instrument for patients undergoing radical cystectomy (RC) and urinary diversion (UD) for bladder cancer that measures five domains: Physical, social, emotional, functional well-being, and a bladder/cystectomy subscale. The initial draft was administered to patients with bladder cancer undergoing RC and UD at two major cancer centers. Statistical methods included principal components analysis, Cronbach’s coefficient alpha, and nonparametric correlation coefficients. The FACT-G was used to test criterion-related validity and a linear mixed model tested the effects of time and diversion type on longitudinal scores. The bladder/cystectomy subscale produced a reliable and valid summary score for bladder cancer patients undergoing RC and UD. MEASURE NAME: Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys) VERSION: 4 NUMBER OF ITEMS: 44 PATIENT POPULATION: Bladder cancer patients 18 years and older undergoing radical cystectomy and urinary diversion RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Bladder/Cystectomy Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. RELATED MEASURES: FACT-Bl , FBlSI , NCCN/FACT FBlSI-18 DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-Bl-Cys can be obtained by registering for permission. Users are not permitted to translate the FACT-Bl-Cys without permission from FACIT.org. Permission from FACIT.org to translate the FACT-Bl-Cys may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Anderson C.B., Feurer I.D., Large M.C., Steinberg G. D., Barocas D.A., Cookson M.S., Penson D.F. Pychometric characteristics of a condition-specific health-related quality-of-life survey: The FACT-Vanderbilt Cystectomy Index. Urology; 80(1): 77-83. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Bl Functional Assessment of Cancer Therapy – Bladder LEARN MORE FBlSI Functional Assessment of Cancer Therapy Bladder Cancer Symptom Index - 7 Item Version LEARN MORE NCCN-FACT FBlSI-18 NCCN/FACT Bladder Symptom Index LEARN MORE

Download scoring documents for this measure. BACK peds FAACT Scoring Downloads Download DOC - Child Download DOC - Adolescent Download DOC - Parent of Child Download DOC - Parent of Adolescent

Download this measure in English. BACK FACT-Br English Downloads Download PDF Download DOC

FAHI Functional Assessment of HIV Infection LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FAHI measure: MEASURE NAME: Functional Assessment of HIV Infection (FAHI) VERSION: 4 NUMBER OF ITEMS: 47 PATIENT POPULATION: HIV patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Emotional Well-Being/Living with HIV, Functional and Global Well-Being, Social Well-Being, Cognitive Functioning TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores available. SAS/SPSS algorithms available. RELATED MEASURES: FAMS , FACIT-Dyspnea , FACIT-TB DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FAHI can be obtained by registering for permission. Users are not permitted to translate the FAHI without permission from FACIT.org. Permission from FACIT.org to translate the FAHI may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Cella, D., Gilet, H., Viala-Danten, M., Peeters, K., Dubois, D., & Martin, S. Effects of etravirine versus placebo on health-related quality of life in treatment-experienced HIV patients as measured by the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) questionnaire in the DUET trials. HIV Clinical Trials 2010; 11(1): 18-27. doi: 10.1310/hct1101-1. Hasanah, C., Zaliha, A., Mahiran, M. Factors influencing the quality of life in patients with HIV in Malaysia. Quality of Life Research 2010; 20(1): 91-100. doi: 10.1007/s11136-010-9729-y. Peterman, A.H., Cella, D., Mo, F., & McCain, N. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Quality of Life Research 1997; 6(6): 572-584. doi: 10.1023/a:1018416317546. Viala-Danten, M., Dubois, D., Gilet, H., Martin, S., Peeters, K., & Cella, D. Psychometric evaluation of the Functional Assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials. Quality Of Life Research.2010; 19(8): 1215-1227. doi: 10.1007/s11136-010-9674-9. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FAMS Functional Assessment of Multiple Sclerosis LEARN MORE FACIT-Dyspnea Functional Assessment of Chronic Illness Therapy - Dyspnea-10 item LEARN MORE FACIT-TB Functional Assessment of Chronic Illness Therapy - Tuberculosis LEARN MORE

Download this measure in English. BACK FHSI English Downloads Download PDF Download DOC

Download scoring documents for this measure. BACK FACT-Br Scoring Downloads Download DOC

View all available languages for this measure. BACK NFHSI-18 Languages Arabic Chinese – Simplified Dutch English French German Hebrew Hungarian Italian Japanese Korean Russian Spanish Thai